India is likely to deliver to Nepal two million doses of the Covishield vaccine manufactured by the Serum Institute of India by October first week.
Although, final date of the vaccine delivery is not yet fixed, officials at the Ministry of Health and Population said that the vaccine will arrive by the said period.
“We have been expecting two million doses of the Covishield vaccine from India soon,” a senior official at the Ministry for Health and Population, told the Post. “Of the two million doses, 1 million doses will be grants from the Indian government.”
The remaining 1 million doses is part of the 2 million doses of the vaccine for which the government had paid Serum in February. The government had purchased 2 million doses of the Covishield vaccine developed by the University of Oxford and Swedish pharmaceutical giant AstraZeneca, with the Serum institute of India, paying $4 per dose in advance.